{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"description":"Engraftment is defined as the first of three consecutive days with ANC \\> 0.5 x 109/L.","groups":[{"description":"Patients with hematologic malignancies requiring UCB transplant with a NMA conditioning regimen.","id":"OG000","title":"HSC835"}],"paramType":"NUMBER","populationDescription":"Safety Analysis Set: The Safety analysis included all enrolled patients who were transplanted with HSC835 (any patient with a date for HSC835 transplant).","reportingStatus":"POSTED","timeFrame":"42 days","title":"Incidence of Neutrophil Recovery Within 42 Days","type":"SECONDARY","unitOfMeasure":"Participants"}